Showing results (51-60 of 983) with videos related to
Sort By:
Pageof 99
Neuroreport|July 12, 2001
Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathiesE Kuusisto, A Salminen, I AlafuzoffNeuropathology and Applied Neurobiology|October 27, 2007
Use of p62/SQSTM1 antibodies for neuropathological diagnosisE Kuusisto, T Kauppinen, I AlafuzoffLakartidningen|September 27, 2001
[Harmonization of dementia diagnoses--a necessary quality assurance]L Berg, L Gustafson, G Hansson, et al.Brain Research|November 20, 1992
Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonistsA L Svensson, I Alafuzoff, A NordbergJournal of Neural Transmission. General Section|January 1, 1994
[3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison studyB Arranz, J MarcussonNeuropsychobiology|January 1, 1989
Inhibition and dissociation of [3H]-paroxetine binding to human plateletsA Andersson, J MarcussonBrain Research|August 2, 1988
[3H]GBR-12935 binding to dopamine uptake sites in the human brainJ Marcusson, K ErikssonTissue Antigens|October 1, 1979
HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinationsJ Marcusson, E MöllerNeurobiology of Aging|November 1, 1990
[3H]paroxetine binding in human platelets in relation to age and sexA Andersson, J MarcussonJournal of Neurochemistry|November 1, 1988
Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake siteJ Marcusson, K ErikssonPageof 99